These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29695193)

  • 1. Efficacy and Safety of Atypical Antipsychotics for Behavioral and Psychological Symptoms of Dementia Among Community Dwelling Adults.
    Trinkley KE; Sturm AM; Porter K; Nahata MC
    J Pharm Pract; 2020 Feb; 33(1):7-14. PubMed ID: 29695193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of atypical antipsychotics for behavioral symptoms of dementia among patients residing in long-term care.
    Sturm AS; Trinkley KE; Porter K; Nahata MC
    Int J Clin Pharm; 2018 Feb; 40(1):135-142. PubMed ID: 29189977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Reported Comparative Effectiveness and Safety of Atypical Antipsychotics in the Treatment of Behavioral and Psychological Symptoms of Dementia: A Network Meta-analysis.
    Yunusa I; Alsumali A; Garba AE; Regestein QR; Eguale T
    JAMA Netw Open; 2019 Mar; 2(3):e190828. PubMed ID: 30901041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use and safety of antipsychotics in behavioral disorders in elderly people with dementia.
    Gareri P; De Fazio P; Manfredi VG; De Sarro G
    J Clin Psychopharmacol; 2014 Feb; 34(1):109-23. PubMed ID: 24158020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Antipsychotics in Patients with Behavioral and Psychological Symptoms of Dementia: Results of a Spanish Delphi Consensus.
    Manzano-Palomo S; Agüera-Ortiz LF; García-Caballero A; Martínez-Raga J; Ojea-Ortega T; Sánchez-Valle R; Antón-Jiménez M; Monge-Argilés JA; Ramos-García I
    Dement Geriatr Cogn Disord; 2020; 49(6):573-582. PubMed ID: 33176326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review.
    Lee PE; Gill SS; Freedman M; Bronskill SE; Hillmer MP; Rochon PA
    BMJ; 2004 Jul; 329(7457):75. PubMed ID: 15194601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuation of Long-Term Antipsychotic Drug Use for Behavioral and Psychological Symptoms in Older Adults Aged 65 Years and Older With Dementia.
    Van Leeuwen E; Petrovic M; van Driel ML; De Sutter AI; Stichele RV; Declercq T; Christiaens T
    J Am Med Dir Assoc; 2018 Nov; 19(11):1009-1014. PubMed ID: 30100234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotics for behavioural and psychological problems in elderly people with dementia: a systematic review of adverse events.
    van Iersel MB; Zuidema SU; Koopmans RT; Verhey FR; Olde Rikkert MG
    Drugs Aging; 2005; 22(10):845-58. PubMed ID: 16245958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Atypical antipsychotics in elderly patients with dementia].
    Selbaek G; Engedal K
    Tidsskr Nor Laegeforen; 2008 May; 128(9):1060-1. PubMed ID: 18451888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are atypical antipsychotics safer than typical antipsychotics for treating behavioral and psychological symptoms of dementia?
    Gurevich A; Guller V; Berner YN; Tal S
    J Nutr Health Aging; 2012; 16(6):557-61. PubMed ID: 22659997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of mortality in atypical antipsychotic-treated community-dwelling elderly patients with behavioural and psychological symptoms of dementia: a prospective population-based cohort study from Italy.
    Rafaniello C; Lombardo F; Ferrajolo C; Sportiello L; Parretta E; Formica R; Potenza S; Rinaldi B; Irpino A; Raschetti R; Vanacore N; Rossi F; Capuano A
    Eur J Clin Pharmacol; 2014 Feb; 70(2):187-95. PubMed ID: 24145814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of antipsychotics among people treated with medications for dementia in residential aged care facilities.
    Shin HY; Gadzhanova S; Roughead EE; Ward MB; Pont LG
    Int Psychogeriatr; 2016 Jun; 28(6):977-82. PubMed ID: 26775538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic drug use and mortality in older adults with dementia.
    Gill SS; Bronskill SE; Normand SL; Anderson GM; Sykora K; Lam K; Bell CM; Lee PE; Fischer HD; Herrmann N; Gurwitz JH; Rochon PA
    Ann Intern Med; 2007 Jun; 146(11):775-86. PubMed ID: 17548409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Antipsychotics for the Treatment of Behavioral Symptoms of Dementia.
    Greenblatt HK; Greenblatt DJ
    J Clin Pharmacol; 2016 Sep; 56(9):1048-57. PubMed ID: 26953213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing Off-Label Antipsychotic Use in Older Community-Dwelling Adults With Dementia: A Narrative Review.
    Bain KT; Schwartz EJ; Chan-Ting R
    J Am Osteopath Assoc; 2017 Jul; 117(7):441-450. PubMed ID: 28662557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quetiapine versus risperidone in elderly patients with behavioural and psychological symptoms of dementia: efficacy, safety and cognitive function.
    Rainer M; Haushofer M; Pfolz H; Struhal C; Wick W
    Eur Psychiatry; 2007 Sep; 22(6):395-403. PubMed ID: 17482432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies.
    Trifiró G; Sultana J; Spina E
    Drug Saf; 2014 Jul; 37(7):501-20. PubMed ID: 24859163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of safety warnings on antipsychotic prescriptions in dementia: nothing has changed but the years and the substances.
    Schulze J; van den Bussche H; Glaeske G; Kaduszkiewicz H; Wiese B; Hoffmann F
    Eur Neuropsychopharmacol; 2013 Sep; 23(9):1034-42. PubMed ID: 23498307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.